HC

Hankang Capital

Venture Capital

Shanghai-based corporate venture capital firm of Zhongjianxin Group, focused on biotech and life sciences investments in China.

Shanghai, China · 5+ investments · 4 portfolio companies

Early Stage
Growth
Biotech
Healthcare
Life Sciences
Headquarters
Shanghai, China
Founded
2010
Portfolio Companies
4
Total Investments
5
Last Investment
Apr 2026
Geographic Focus
China

Investment Thesis

Focuses on in-depth research in biotech opportunities in China, investing in 50+ high-potential companies including sector leaders in oncology and pharmaceuticals.

Hankang Capital is a Venture Capital firm based in Shanghai, China. It has made 5 investments, including Vivacta Biotechnology, Proviva Therapeutics and AusperBio. Focus areas include Biotech and Healthcare.

Portfolio4

Co-investors14

Sign up to view co-investors

14 co-investors across 17 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×11 · Private Equity ×1 · Hedge Fund ×1 · 17 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Hankang Capital on Indexed.vc
<a href="https://indexed.vc/investors/hankang-capital"><img src="https://indexed.vc/api/badge/investor/hankang-capital" alt="Hankang Capital on Indexed.vc" width="260" height="76" /></a>